Skip to main content
OpenTrials
Completed

NCT Number: NCT04064801

Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning

The study aimed to investigate the association between RDW and in-hospital mortality in methanol poisoning.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Methanol Poisoning

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Adana City Training and Research Hospital

Adana, 01170, Turkey (Türkiye)

About this study

RDW values have been found to be an independent predictor of the prognosis among patients with heart diseases, stroke,community-acquired pneumonia (CAP), pulmonary embolism, chronic obstructive pulmonary disease (COPD), septic shock, and acute pancreatitis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients aged ≥18 years who were admitted to emergency departments from January 2019 to January 2020 on account of acute methanol intoxication.

Exclusion criteria

Incomplete data, Malignancy, Severe anaemia, History of erythrocyte transfusion last 6 weeks

-

Treatment and study plan

Primary outcomes

  1. Hospital mortality

    Time frame: 7 day

  2. Need for mechanical ventilation

    Time frame: 7 day

Sponsors and collaborators

Lead sponsor

Adana Numune Training and Research Hospital

Other Gov

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Aug 22, 2019
Registry last updated
Apr 15, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.